Severe Pneumonia in Mozambican Young Children: Clinical and Radiological Characteristics and Risk Factors

被引:48
作者
Sigauque, Betuel [1 ,2 ]
Roca, Anna [2 ]
Bassat, Quique [2 ]
Morais, Luis
Quinto, Llorenc [4 ]
Berenguera, Anna
Machevo, Sonia [3 ]
Bardaji, Azucena [4 ]
Corachan, Manuel
Ribo, Josep [2 ,4 ]
Menendez, Clara [4 ]
Schuchat, Anne [5 ]
Flannery, Brendan [5 ]
Soriano-Gabarro, Montse [5 ]
Alonso, Pedro L. [2 ]
机构
[1] Minist Saude, Inst Nacl Saude, CISM, Maputo, Mozambique
[2] Univ Barcelona, IDIBAPS, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, E-08007 Barcelona, Spain
[3] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique
[4] Hosp Univ St Joan de Deu, Barcelona, Spain
[5] CDC, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
关键词
Mozambique; children; pneumonia; risk factors; mortality; RESPIRATORY-TRACT INFECTIONS; CHILDHOOD PNEUMONIA; AFRICAN CHILDREN; RURAL MOZAMBIQUE; PREGNANT-WOMEN; DISEASE BURDEN; MALARIA; COMMUNITY; MANHICA; DEFINITION;
D O I
10.1093/tropej/fmp030
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Pneumonia is a leading cause of hospitalization and death among children in Africa. We describe the clinical presentation of severe pneumonia among hospitalized children in a malaria endemic area with a high prevalence of HIV infection. Methods: As part of a 2-year prospective study of radiologically confirmed pneumonia, chest radiographs, malaria parasite counts and bacterial blood cultures were systematically performed for children 0-23 months admitted with severe pneumonia. Radiographs were interpreted according to WHO guidelines. HIV tests were performed during a 12-month period. Results: Severe pneumonia accounted for 16% of 4838 hospital admissions among children 0-23 months; 43% of episodes had endpoint consolidation, 15% were associated with bacteremia and 11% were fatal. Fever, cough > 3 days, crepitations, hypoxemia and absence of malaria parasitemia were associated with radiologically confirmed pneumonia. Nineteen per cent of children with severe pneumonia and 27% with radiologically confirmed pneumonia had clinical malaria. HIV-prevalence was 26% among children hospitalized with severe pneumonia and HIV-testing results. HIV infection, anaemia, malnutrition, hypoxemia and bacteremia were associated with fatal episodes of severe pneumonia. Conclusion: Treatment of admitted children with severe pneumonia is complicated in settings with prevalent HIV and malaria. Children with severe pneumonia and clinical malaria require antibiotic and antimalarial treatment. In addition to vertical programs, integrated approaches may greatly contribute to reduction of pneumonia-related mortality.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 43 条
  • [1] Alonso P, 2002, POPULATION HLTH DEV, V1
  • [2] Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
    Alonso, PL
    Sacarlal, J
    Aponte, JJ
    Leach, A
    Macete, E
    Milman, J
    Mandomando, I
    Spiessens, B
    Guinovart, C
    Espasa, M
    Bassat, Q
    Aide, P
    Ofori-Anyinam, O
    Navia, MM
    Corachan, S
    Ceuppens, M
    Dubois, MC
    Demoitié, MA
    Dubovsky, F
    Menéndez, C
    Tornieporth, N
    Ballou, WR
    Thompson, R
    Cohen, J
    [J]. LANCET, 2004, 364 (9443) : 1411 - 1420
  • [3] [Anonymous], 2000, Adv Data
  • [4] Aranda C, 2005, J MED ENTOMOL, V42, P180, DOI 10.1603/0022-2585(2005)042[0180:ECOMTI]2.0.CO
  • [5] 2
  • [6] Case management of childhood pneumonia in developing countries
    Ayieko, Philip
    English, Mike
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (05) : 432 - 440
  • [7] Bonadio W A, 1988, Pediatr Emerg Care, V4, P241, DOI 10.1097/00006565-198812000-00002
  • [8] Salmonella bacteremia in Kenyan children
    Brent, AJ
    Oundo, JO
    Mwangi, I
    Ochola, L
    Lowe, B
    Berkley, JA
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (03) : 230 - 236
  • [9] Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353
  • [10] Operational challenges in large clinical trials: Example lessons learned from the Gambia pneumococcal vaccine
    Cutts, F. T.
    Enwere, G.
    Zaman, S. M. A.
    Yallop, F. G.
    [J]. PLOS CLINICAL TRIALS, 2006, 1 (03):